Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 118

1.

Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study.

Whitney CG, Pilishvili T, Farley MM, Schaffner W, Craig AS, Lynfield R, Nyquist AC, Gershman KA, Vazquez M, Bennett NM, Reingold A, Thomas A, Glode MP, Zell ER, Jorgensen JH, Beall B, Schuchat A.

Lancet. 2006 Oct 28;368(9546):1495-502.

PMID:
17071283
2.

Effectiveness of ten-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in Brazil: a matched case-control study.

Domingues CM, Verani JR, Montenegro Renoiner EI, de Cunto Brandileone MC, Flannery B, de Oliveira LH, Santos JB, de Moraes JC; Brazilian Pneumococcal Conjugate Vaccine Effectiveness Study Group.

Lancet Respir Med. 2014 Jun;2(6):464-71. doi: 10.1016/S2213-2600(14)70060-8. Epub 2014 Apr 10.

PMID:
24726406
3.

Effectiveness of 7-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in HIV-infected and -uninfected children in south africa: a matched case-control study.

Cohen C, von Mollendorf C, de Gouveia L, Naidoo N, Meiring S, Quan V, Nokeri V, Fortuin-de Smit M, Malope-Kgokong B, Moore D, Reubenson G, Moshe M, Madhi SA, Eley B, Hallbauer U, Kularatne R, Conklin L, O'Brien KL, Zell ER, Klugman K, Whitney CG, von Gottberg A; South African Invasive Pneumococcal Disease Case-Control Study Group.

Clin Infect Dis. 2014 Sep 15;59(6):808-18. doi: 10.1093/cid/ciu431. Epub 2014 Jun 9.

5.

The effect of an alternative reduced-dose infant schedule and a second year catch-up schedule with 7-valent pneumococcal conjugate vaccine on pneumococcal carriage: a randomized controlled trial.

Dagan R, Givon-Lavi N, Porat N, Greenberg D.

Vaccine. 2012 Jul 20;30(34):5132-40. doi: 10.1016/j.vaccine.2012.05.059. Epub 2012 Jun 6.

PMID:
22683519
6.

Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Weil-Olivier C, van der Linden M, de Schutter I, Dagan R, Mantovani L.

BMC Infect Dis. 2012 Sep 7;12:207. doi: 10.1186/1471-2334-12-207. Review.

7.
8.

Invasive pneumococcal infections among vaccinated children in the United States.

Park SY, Van Beneden CA, Pilishvili T, Martin M, Facklam RR, Whitney CG; Active Bacterial Core surveillance team.

J Pediatr. 2010 Mar;156(3):478-483.e2. doi: 10.1016/j.jpeds.2009.10.008. Epub 2009 Dec 3.

PMID:
19962156
9.

Laboratory surveillance of invasive pneumococcal disease in Australia in 2001 to 2002--implications for vaccine serotype coverage.

Watson M, Bayley K, Bell JM, Gilbert GL, Hogg G, Keil AD, Krause V, Murphy D, Roche P, Smith HV, Stewart MG, Stylianopoulos J, Turnidge J.

Commun Dis Intell Q Rep. 2003;27(4):478-87.

10.

Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.

Steens A, Bergsaker MA, Aaberge IS, Rønning K, Vestrheim DF.

Vaccine. 2013 Dec 16;31(52):6232-8. doi: 10.1016/j.vaccine.2013.10.032. Epub 2013 Oct 29.

PMID:
24176490
11.

Effectiveness of the ten-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine (PHiD-CV10) against invasive pneumococcal disease: a cluster randomised trial.

Palmu AA, Jokinen J, Borys D, Nieminen H, Ruokokoski E, Siira L, Puumalainen T, Lommel P, Hezareh M, Moreira M, Schuerman L, Kilpi TM.

Lancet. 2013 Jan 19;381(9862):214-22. doi: 10.1016/S0140-6736(12)61854-6. Epub 2012 Nov 16. Erratum in: Lancet. 2015 May 30;385(9983):2152. Lancet. 2013 May 18;381(9879):1720.

PMID:
23158882
12.

Effectiveness of 7-valent pneumococcal conjugate vaccine in the prevention of invasive pneumococcal disease in children aged 7-59 months. A matched case-control study.

Domínguez A, Ciruela P, García-García JJ, Moraga F, de Sevilla MF, Selva L, Coll F, Muñoz-Almagro C, Planes AM, Codina G, Jordán I, Esteva C, Hernández S, Soldevila N, Cardeñosa N, Batalla J, Salleras L.

Vaccine. 2011 Nov 8;29(48):9020-5. doi: 10.1016/j.vaccine.2011.09.034. Epub 2011 Sep 20.

PMID:
21939724
13.

[A pediatric case of pneumococcal meningitis due to Streptococcus pneumoniae serotype 35F].

Kara SS, Polat M, Tapisiz A, Nar Otgun S, Tezer H.

Mikrobiyol Bul. 2014 Apr;48(2):346-50. Turkish.

14.

Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study.

Miller E, Andrews NJ, Waight PA, Slack MP, George RC.

Lancet Infect Dis. 2011 Oct;11(10):760-8. doi: 10.1016/S1473-3099(11)70090-1. Epub 2011 May 27.

PMID:
21621466
15.

Emerging pneumococcal carriage serotypes in a high-risk population receiving universal 7-valent pneumococcal conjugate vaccine and 23-valent polysaccharide vaccine since 2001.

Leach AJ, Morris PS, McCallum GB, Wilson CA, Stubbs L, Beissbarth J, Jacups S, Hare K, Smith-Vaughan HC.

BMC Infect Dis. 2009 Aug 4;9:121. doi: 10.1186/1471-2334-9-121.

16.

Anticapsular serum antibody concentration and protection against pneumococcal colonization among children vaccinated with 7-valent pneumococcal conjugate vaccine.

Millar EV, O'Brien KL, Bronsdon MA, Madore D, Hackell JG, Reid R, Santosham M.

Clin Infect Dis. 2007 May 1;44(9):1173-9. Epub 2007 Mar 23.

17.
18.

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.

Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance of the Emerging Infections Program Network.

N Engl J Med. 2006 Apr 6;354(14):1455-63. Erratum in: N Engl J Med. 2006 Aug 10;355(6):638.

19.

Effectiveness of the 7-valent pneumococcal conjugate vaccine against vaccine-type invasive disease among children in Uruguay: an evaluation using existing data.

Picón T, Alonso L, García Gabarrot G, Speranza N, Casas M, Arrieta F, Camou T, Rosa R, De Oliveira LH, Verani JR.

Vaccine. 2013 Jul 2;31 Suppl 3:C109-13. doi: 10.1016/j.vaccine.2013.01.059. Review.

PMID:
23777683
20.

Surveillance for invasive pneumococcal disease during 2000-2005 in a population of children who received 7-valent pneumococcal conjugate vaccine.

Black S, France EK, Isaacman D, Bracken L, Lewis E, Hansen J, Fireman B, Austrian R, Graepel J, Gray S, Klein NP.

Pediatr Infect Dis J. 2007 Sep;26(9):771-7.

PMID:
17721369
Items per page

Supplemental Content

Write to the Help Desk